XML 59 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Collaboration Agreements And In-Licensing Arrangements - GSK (Details) - USD ($)
$ in Millions
3 Months Ended
Apr. 02, 2021
Apr. 03, 2020
Collaboration Agreement with GlaxoSmithKline    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Royalty expense $ 10.1 $ 8.1
GSK    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percent of royalty on net sale 3.00%